The Dilemma of Fluid Management in Acute Kidney Injury During Sickle Cell Crises: A Case Report

Main Article Content

Adebukola Ajite
Ezra Ogundare
Ademola Fasanmi
Benjamin Ilori

Abstract

Fluid therapy remains a cornerstone in the management of sickle cell crises, as adequate hydration reduces blood viscosity and limits further sickling. However, in the presence of oliguric Acute Kidney Injury (AKI), fluid administration becomes a delicate balance to prevent volume overload and worsen morbidity. The case is that of an 8-year-old known sickle cell anemic boy who presented with fever and bone pain for 3 days, jaundice, and passage of dark brown urine. He was pale, icteric, and had non-tender hepatomegaly. He was managed for Vaso-occlusive crisis (VOC) and hyperhaemolytic crisis due to presumed sepsis. He had a blood transfusion and was subsequently placed on intravenous fluids 5% Dextrose in 0.9% Saline at 120% of maintenance. He developed Acute Kidney Injury (AKI) with oliguria (urine output 0.3ml/kg/hr), elevated serum urea (17.70mmol/L), creatinine (241.4µmol/L), and hyperkalemia (K 5.58mmol/L) by the following day on admission. His systolic blood pressure ranged from 140 to 100mmHg, while the diastolic ranged from 100mmHg to 60mmHg. In view of the oliguric AKI, the intravenous fluid was reduced to 2/3rd of maintenance fluid using 5% Dextrose Saline, while the remaining 1/3rd was given orally. He was given furosemide with alkalization of the urine. His urine output and vital signs were closely monitored, and hyperkalemia and hypertension were managed appropriately. By the end of the first week of admission, there was significant improvement in renal parameters, and urine output normalized. The blood pressure at discharge was 90/60mmHg. In conclusion, balancing adequate hydration to prevent further sickling must be weighed against the risk of fluid overload and worsening renal dysfunction in co-existing AKI.

Downloads

Download data is not yet available.

Article Details

Ajite, A., Ogundare, E., Fasanmi, A., & Ilori, B. (2026). The Dilemma of Fluid Management in Acute Kidney Injury During Sickle Cell Crises: A Case Report. Global Journal of Medical and Clinical Case Reports, 128–131. https://doi.org/10.17352/gjmccr.000255
Case Reports

Copyright (c) 2026 Ajite A, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Baddam S, Rout P. Sickle Cell Nephropathy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026-. Updated 2025 Jun 2.

Chakravorty S, Williams TN. Sickle cell disease: a neglected chronic disease of increasing global health importance. Arch Dis Child. 2015;100(1):48-53. Available from: https://doi.org/10.1136/archdischild-2013-303773

McGann PT, Hernandez AG, Ware RE. Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research. Blood. 2017;129(2):155-161. Available from: Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research. Blood. 2017;129(2):155-161 https://doi.org/10.1182/blood-2016-09-702324

Dvanajscak Z, Walker PD, Cossey LN, Messias NC, Boils CL, Kuperman MB, Larsen CP. Hemolysis-associated hemoglobin cast nephropathy results from a range of clinicopathologic disorders. Kidney Int. 2019;96(6):1400-1407. Available from: https://doi.org/10.1016/j.kint.2019.08.026

Kopac M. Acute kidney injury in children: classification, recognition and treatment principles. Children (Basel). 2024;11(11):1308. Available from: https://doi.org/10.3390/children11111308

Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1-138. Available from: https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-AKI-Guideline-English.pdf

Holley JL. Clinical approach to the diagnosis of acute renal failure. In: Greenberg A, Cheung AK, Coffman TM, Falk RJ, Jennette JC, editors. Primer on Kidney Diseases. 5th ed. Philadelphia: Saunders Elsevier; 2009. p. 277-283.

Nair RK, Khaira A, Sharma A, Mahajan S, Dinda AK. Spectrum of renal involvement in paroxysmal nocturnal hemoglobinuria: a report of three cases and a brief review of the literature. Int Urol Nephrol. 2008;40(2):471-475. Available from: https://doi.org/10.1007/s11255-008-9356-5

Darbari DS, Onyekwere O, Nouraie M, Minniti CP, Luchtman-Jones L, Rana S, et al. Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study. PLoS One. 2013;8(11):e79923. Available from: https://doi.org/10.1371/journal.pone.0079923

Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, et al. Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom. PLoS One. 2014;9(7):e99489. Available from: https://doi.org/10.1371/journal.pone.0099489

Elmariah H, Garrett ME, De Castro LM, Jonassaint JC, Ataga KI, Eckman JR, et al. Factors associated Available from:with survival in a contemporary adult sickle cell disease cohort. Am J Hematol. 2014;89(5):530-535. Available from: https://doi.org/10.1002/ajh.23683

Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639-1644. Available from: https://doi.org/10.1056/nejm199406093302303

Hamideh D, Alvarez O. Sickle cell disease-related mortality in the United States, 1999-2009. Pediatr Blood Cancer. 2013;60(9):1482-1486. Available from: https://doi.org/10.1002/pbc.24557

Deuel JW, Schaer CA, Boretti FS, Opitz L, Garcia-Rubio I, Baek JH, et al. Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response. Cell Death Dis. 2016;7(1):e2064. Available from: https://doi.org/10.1038/cddis.2015.392

Sakthiswary R, Das S, Fadilah SA. Successful treatment of acute kidney injury secondary to haemoglobinuria in paroxysmal nocturnal haemoglobinuria with alkaline diuresis. EXCLI J. 2012;11:198-203.

Tsai CW, Wu VC, Lin WC, Huang JW, Wu MS. Acute renal failure in a patient with paroxysmal nocturnal hemoglobinuria. Kidney Int. 2007;71(11):1187. Available from: https://doi.org/10.1038/sj.ki.5002179

Ullah MM, Basile DP. Role of renal hypoxia in the progression from acute kidney injury to chronic kidney disease. Semin Nephrol. 2019;39(6):567-580. Available from: https://doi.org/10.1016/j.semnephrol.2019.10.006

Okomo U, Meremikwu M. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. Cochrane Database Syst Rev. 2017;7:CD005406. Available from: https://doi.org/10.1002/14651858.cd005406.pub5

Esson ML, Schrier RW. Diagnosis and treatment of acute tubular necrosis. Ann Intern Med. 2002;137(9):744-752. Available from: https://doi.org/10.7326/0003-4819-137-9-200211050-00010

Atoyebi W. Acute kidney injury in patients with sickle cell disease: clinical guideline. Wessex and Thames Valley Haemoglobinopathy Network, Adult Haemoglobinopathy Service, NHS. Available from: https://nssg.oxford-haematology.org.uk/red-cell/documents/acute-management-sickle-cell-disease/S15-acute-kidney-injury-in-scd.pdf

Ataga KI, Saraf SL, Derebail VK. The nephropathy of the sickle cell trait and sickle cell disease. Nat Rev Nephrol. 2022;18(6):361-377. Available from: https://doi.org/10.1038/s41581-022-00540-9

Aleem A, Al-Sultan A, Sharif M, Alotaibi DS. Response to lisinopril in patients with sickle cell anaemia and proteinuria. Saudi J Kidney Dis Transpl. 2023;34(6):531-536. Available from: https://doi.org/10.4103/sjkdt.sjkdt_312_22